What kind of medicine is Melphalan/Melphalan tablets?

Melphalan/Melphalan tablets (Melphalan) is an anti-tumor drug mainly used to treat multiple myeloma and certain types of lymphoma. It is an alkylating agent that inhibits the proliferation of cancer cells by binding to DNA. Melphalan tabletscontain the main ingredient melphalan. Its mechanism of action is mainly by causing cross-linking ofDNA chains during the process of cell development, causing cellsto be unable to replicate normally, thereby inducing cell apoptosis.

Melphalan tablets are generally administered orally, and the specific dosage regimen depends on the patient's condition, tolerance, and doctor's treatment plan. In the treatment of multiple myeloma, melphalan tablets are often combined with other drugs to enhance the efficacy. For example, it can be used with corticosteroids or other chemotherapy drugs. The effectiveness of treatment often requires periodic monitoring to assess tumor response and patient tolerance.

Although melphalan tablets have achieved some success in treating some malignant tumors, their use is also associated with some side effects. Common side effects include bone marrow suppression, which may lead to a decrease in white blood cells, red blood cells, and platelets, thereby increasing the risk of infection, causing anemia, and bleeding tendencies. In addition, patients may experience gastrointestinal reactions, such as nausea, vomiting, diarrhea, etc. The severity of these side effects varies from individual to individual, so during treatment, doctors usually closely monitor the patient's blood indicators in order to adjust the treatment plan in a timely manner.

Long-term use of melphalan may increase the risk of certain types of cancer, especially secondary malignancies. Therefore, when formulating a treatment plan, doctors will consider the patient's medical history and potential risks to develop the most appropriate treatment strategy. When using melphalan for treatment, patients need to follow the doctor's guidance, undergo regular blood tests, and promptly report any symptoms of discomfort so that the treatment plan can be adjusted.